CompletedNot applicableNCT05183776
Clinical Validation of a Fractional Administration Device for Holmium-166 SIRT
Studying Rare tumor of liver and intrahepatic biliary tract
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Radboud University Medical Center
- Principal Investigator
- Frank Nijsen, PhD.Associate professor
- Intervention
- Fractional administration device(device)
- Enrollment
- 5 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2023
Study locations (1)
- RadboudUMC, Nijmegen, Netherlands
Collaborators
Terumo Medical Corporation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05183776 on ClinicalTrials.govOther trials for Rare tumor of liver and intrahepatic biliary tract
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07356531Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver CancerJIANGSU SHENMING Medical Technology CO., Ltd
- ACTIVE NOT RECRUITINGNCT04145141National Translational Science Network of Precision-based Immunotherapy for Primary Liver CancerNational Cancer Institute (NCI)
- ACTIVE NOT RECRUITINGNANCT02984566Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)University of Sydney
See all trials for Rare tumor of liver and intrahepatic biliary tract →